Inhibition of constitutively activated Stat3 correlates with altered Bcl-2/Bax expression and induction of apoptosis in mycosis fungoides tumor cells

被引:176
作者
Nielsen, M
Kæstel, CG
Eriksen, KW
Woetmann, A
Stokkedal, T
Kaltoft, K
Geisler, C
Röpke, C
Odum, N
机构
[1] Univ Copenhagen, Inst Med Microbiol & Immunol, DK-2200 Copenhagen N, Denmark
[2] Univ Copenhagen, Inst Med Anat, Sect A, DK-2200 Copenhagen, Denmark
[3] Univ Aarhus, Inst Human Genet, Aarhus, Denmark
关键词
Stat3; apoptosis; mycosis fungoides; T cells;
D O I
10.1038/sj.leu.2401415
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The Jak/Stat signaling pathway transmits signals from many cytokine and growth factor receptors to target genes in the nucleus. Constitutive activation of Stat3 has recently been observed in many tumor cells and dysregulation of the Stat signaling pathway has been proposed to be implicated in malignant transformation. In a previous study, we found constitutively tyrosine phosphorylated Stat3 in mycosis fungoides tumor cells. Here, we show that the Jak kinase inhibitor, Ag490, inhibits the constitutive binding of Stat3 to an oligonucleotide representing the Stat-binding sequence from the ICAM promotor. The decreased ability of Stat3 to bind DNA precedes dynamic alterations in the expression of anti-apoptotic Bcl-2 and pro-apoptotic Bax proteins (decreased Bcl-2 expression and increased Bax expression) and induction of apoptosis. Thus, our data suggest that the involvement of Stat3 in oncogenic transformation could be mediated through regulation of survival signals.
引用
收藏
页码:735 / 738
页数:4
相关论文
共 18 条
  • [1] Stat3 activation is required for cellular transformation by v-src
    Bromberg, JF
    Horvath, CM
    Besser, D
    Lathem, WW
    Darnell, JE
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (05) : 2553 - 2558
  • [2] STAT3 beta, a splice variant of transcription factor STAT3, is a dominant negative regulator of transcription
    Caldenhoven, E
    vanDijk, TB
    Solari, R
    Armstrong, J
    Raaijmakers, JAM
    Lammers, JWJ
    Koenderman, L
    deGroot, RP
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (22) : 13221 - 13227
  • [3] Chai SK, 1997, J IMMUNOL, V159, P4720
  • [4] Constantin G, 1998, EUR J IMMUNOL, V28, P3523, DOI 10.1002/(SICI)1521-4141(199811)28:11<3523::AID-IMMU3523>3.0.CO
  • [5] 2-X
  • [6] Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: Involvement of STAT3 in anti-apoptosis
    Fukada, T
    Hibi, M
    Yamanaka, Y
    TakahashiTezuka, M
    Fujitani, Y
    Yamaguchi, T
    Nakajima, K
    Hirano, T
    [J]. IMMUNITY, 1996, 5 (05) : 449 - 460
  • [7] GouilleuxGruart V, 1996, BLOOD, V87, P1692
  • [8] KALTOFT K, 1992, IN VITRO CELL DEV-AN, V28A, P161
  • [9] CYTOGENETIC FINDINGS IN CELL-LINES FROM CUTANEOUS T-CELL LYMPHOMA
    KALTOFT, K
    HANSEN, BH
    THESTRUPPEDERSEN, K
    [J]. DERMATOLOGIC CLINICS, 1994, 12 (02) : 295 - 304
  • [10] Mitochondrial control of apoptosis
    Kroemer, G
    Zamzami, N
    Susin, SA
    [J]. IMMUNOLOGY TODAY, 1997, 18 (01): : 44 - 51